Matthew D. Keller

Loss of BAP1 function leads to EZH2-dependent transformation

Lindsay M. LaFave, Wendy Béguelin, Richard P. Koche et al. · Nature Medicine · 2015 · 392 citations · Full text

Chromatin, Signal Transduction, Signal Recognition +3

JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response

Maria Kleppe, Minsuk Kwak, Priya Koppikar et al. · Cancer Discovery · 2015 · 302 citations · Full text

Near-infrared autofluorescence for the detection of parathyroid glands

Constantine Paras, Matthew D. Keller, Lisa White et al. · Journal of Biomedical Optics · 2011 · 300 citations

Engineering, Parathyroid Disease, Parathyroid Gland +16

Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms

Maria Kleppe, Richard P. Koche, Lihua Zou et al. · Cancer Cell · 2017 · 277 citations · Full text

Hematological Malignancy, Oncogenic Activation, Malignant Blood Disorder +10

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

Olga A. Guryanova, Kaitlyn Shank, Barbara Spitzer et al. · Nature Medicine · 2016 · 243 citations · Full text

Hematological Malignancy, Chromatin, Mixed-phenotype Acute Leukemia +10